<DOC>
	<DOCNO>NCT01563003</DOCNO>
	<brief_summary>Due considerable prevalence anxiety youth autism spectrum disorder , study seek establish efficacy modified cognitive behavioral therapy protocol 50 adolescent versus available treatment option .</brief_summary>
	<brief_title>Cognitive Behavioral Therapy Anxiety Disorders Adolescents With Autism</brief_title>
	<detailed_description>This study examine treatment plan adolescents autism spectrum disorderS ( ASD ) anxiety . Many child autism spectrum disorder experience substantial anxiety cause impairment ASD alone . Few study examine effective treatment option anxiety population . In typically develop youth , Cognitive Behavioral Therapy ( CBT ) consider gold standard treat anxiety . But , order address unique need child ASD , study utilizes modify CBT treatment plan include social skill parent training . In past study , cognitive-behavioral treatment plan effective kid ASD anxiety compare kid receive treatment.The current study compare modify treatment plan treatment option community . The experimental component study assign 1 2 group . The first group receive CBT immediately period 16 week . The second group wait 16 week receive CBT . During time period , child may receive service community . Overall , adolescent receive type therapy ; 's matter whether he/she receives immediately wait period . Sixteen weekly session comprise CBT . All therapy assessment associate study free charge .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Developmental Disabilities</mesh_term>
	<mesh_term>Anxiety , Separation</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Asperger Syndrome</mesh_term>
	<criteria>1 . Outpatient child autism spectrum disorder ( see # 2 ) age 1116 year . 2 . Meets criteria diagnosis autism , Asperger syndrome ( AS ) , PDDNOS use score Autism Diagnostic InterviewRevised Childhood Autism Rating Scale . 3 . Meets DSMIV criterion diagnosis one follow anxiety disorder : separation anxiety disorder ( SAD ) , generalize anxiety disorder ( GAD ) , social phobia , obsessive compulsive disorder ( OCD ) determine ADISIVC/P ( CSR 4 ) available information . 4 . Minimum score 13 PARS Severity Scale ; score indicate clinically significant anxiety symptom severity ( RUPP , 2002 ) use recent major clinical trial ( e.g. , Walkup et al. , 2008 ) . 5 . Child Full Scale Verbal Comprehension IQ &gt; 80 assess commonly use IQ test . 6 . Subjects comorbid depression , ADHD , tic disorder disruptive behavior disorder acceptable long anxiety disorder primary ( i.e. , impairing/distressing ) . 1 . Receiving concurrent psychotherapy , social skill training , behavioral intervention ( e.g. , apply behavior analysis ) . Families option discontinue service enroll study . 2 . New Treatments : Initiation antidepressant within 12 week study enrollment antipsychotic 6 week study enrollment . No new alternative medication , nutritionals therapeutic diet within 6 week study enrollment . 3 . Established Treatment change : Any change establish psychotropic medication ( e.g. , antidepressant , anxiolytic ) within 8 week study enrollment ( 6 week antipsychotic ) . Alternative medication might behavioral effect must stable 6 week prior study baseline assessment . Any medication adolescent must remain stable treatment . If potential participant take psychotropic medication time phone evaluation first inperson study assessment wish discontinue medication enter study , patient ask discuss option prescribe physician determine whether medication discontinuation would safe adolescent 's best interest . In addition , obtain patient 's write consent contact treat clinician determine appropriateness study participation . We influence decision patient make prescribe physician . All pharmacotherapy recommendation make consultation Dr. Murphy . 4 . ( ) Current clinically significant suicidality ( b ) individual engage suicidal behavior within 6 month exclude referred appropriate clinical intervention . 5 . Lifetime DSMIV bipolar , schizophrenia schizoaffective disorder ; Substance abuse past 6 month . 6 . Unwillingness parent make commitment accompany child multiple study visit . 7 . Presence significant and/or unstable medical illness might lead hospitalization study .</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Autism</keyword>
	<keyword>Asperger 's Syndrome</keyword>
	<keyword>Pervasive Developmental Disorder Not Otherwise Specified</keyword>
	<keyword>Treatment</keyword>
	<keyword>Cognitive-behavioral therapy</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Children</keyword>
	<keyword>Therapy</keyword>
</DOC>